by Sue Robbins | Jan 27, 2021 | Migraine
US-Israeli prescribed digital therapeutics firm Theranica, a company that develops advanced electroceuticals for migraine and other pain conditions, announced on Monday that its Nerivio therapeutic device has received clearance from the US Food and Drug Administration...
by Sue Robbins | Jan 26, 2021 | Miscellaneous
Researchers found that levels of a nerve growth factor were lower in people with depression or bipolar disorder than in healthy controls. Doctors could potentially use levels of the growth factor to monitor the effects of antidepressant treatment. In adults, a protein...
by Sue Robbins | Jan 25, 2021 | Miscellaneous
(CNN) — Whether winter makes you want to sleep all day, you experience a slight case of the “winter blues” or you’ve been diagnosed with seasonal affective disorder (SAD), you may have considered purchasing a light therapy lamp — or, as it’s often called, a SAD lamp...
by Sue Robbins | Jan 21, 2021 | Migraine
The migraine prevention drug erenumab (Aimovig) was associated with elevated blood pressure (BP), an FDA analysis of postmarketing case reports suggested. Of 61 erenumab-linked hypertension cases submitted to the FDA Adverse Event Reporting System (FAERS), 41 were...
by Sue Robbins | Jan 20, 2021 | Miscellaneous
In the first joint replacement surgery in 1890, the German surgeon Themistocles Gluck implanted “carved and machined pieces of ivory” into joints diseased by tuberculosis — starting with a knee replacement for a 17-year-old girl, according to the medical historian and...
